Bamboos Health Care Holdings Limited carries a market capitalization of 146.17M, placing it among publicly traded companies globally. Its enterprise value stands at 434.95M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 146.17M |
| Enterprise Value | 434.95M |
Bamboos Health Care Holdings Limited currently has 400.00M shares outstanding.
| Shares Outstanding | 400.00M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Bamboos Health Care Holdings Limited trades at a trailing price-to-earnings ratio of 18.08. The price-to-sales ratio is 9.38, and the price-to-book ratio stands at 9.25.
| PE Ratio | 18.08 |
| PS Ratio | 9.38 |
| PB Ratio | 9.25 |
| P/TBV Ratio | 5.49 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
The EV/Sales ratio of 7.72 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 12.25 provides insight into valuation relative to core operating earnings.
| EV / Sales | 7.72 |
| EV / EBITDA | 12.25 |
| EV / EBIT | 12.25 |
| EV / FCF | N/A |
Bamboos Health Care Holdings Limited maintains a current ratio of 5.47, meaning it holds 5.5x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 5.47 |
| Quick Ratio | 4.38 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Bamboos Health Care Holdings Limited posts a return on equity of 61.46 and a return on invested capital of 32.13.
| Return on Equity (ROE) | 61.46 |
| Return on Assets (ROA) | 27.69 |
| Return on Invested Capital (ROIC) | 32.13 |
| Return on Capital Employed (ROCE) | 61.46 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Over the trailing twelve months, Bamboos Health Care Holdings Limited has paid 6.44M in income taxes, reflecting an effective tax rate of 18.07.
| Income Tax | 6.44M |
| Effective Tax Rate | 18.07 |
Bamboos Health Care Holdings Limited's stock has declined approximately -27% over the past 52 weeks. The 50-day moving average sits at 0.39, while the 200-day moving average is 0.47.
| Beta (5Y) | N/A |
| 52-Week Price Change | -27% |
| 50-Day Moving Average | 0.39 |
| 200-Day Moving Average | 0.47 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Bamboos Health Care Holdings Limited generated 56.32M in revenue and converted that into 29.20M in net income, yielding earnings per share of 0.07. EBITDA reached 35.49M, while operating income came in at 35.49M.
| Revenue | 56.32M |
| Gross Profit | N/A |
| Operating Income | 35.49M |
| Pretax Income | 35.64M |
| Net Income | 29.20M |
| EBITDA | 35.49M |
| EBIT | 35.49M |
| Earnings Per Share (EPS) | 0.07 |
Total book value stands at 57.11M, with working capital of 95.15M providing operational flexibility.
| Cash & Cash Equivalents | 93.07M |
| Total Debt | N/A |
| Net Debt | -93.07M |
| Equity (Book Value) | 57.11M |
| Book Value Per Share | 0.14 |
| Working Capital | 95.15M |
Bamboos Health Care Holdings Limited operates with a gross margin of 100.00, reflecting its pricing power and cost economics. The operating margin of 63.03 and net profit margin of 51.85 provide insight into operational efficiency.
| Gross Margin | 100.00 |
| Operating Margin | 63.03 |
| Pretax Margin | 63.29 |
| Profit Margin | 51.85 |
| EBITDA Margin | 63.03 |
Bamboos Health Care Holdings Limited posts an Altman Z-Score of 17.94, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 17.94 |